| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Persistent Fetal Circulation Syndrome | 31 | 2026 | 86 | 9.090 |
Why?
|
| Forkhead Transcription Factors | 34 | 2026 | 373 | 8.220 |
Why?
|
| T-Box Domain Proteins | 13 | 2026 | 122 | 6.350 |
Why?
|
| DNA Copy Number Variations | 60 | 2026 | 1021 | 5.810 |
Why?
|
| Sequence Deletion | 38 | 2026 | 517 | 5.570 |
Why?
|
| Mosaicism | 20 | 2022 | 247 | 4.920 |
Why?
|
| Gene Duplication | 33 | 2025 | 358 | 4.290 |
Why?
|
| Comparative Genomic Hybridization | 61 | 2020 | 567 | 3.780 |
Why?
|
| Lung | 21 | 2025 | 1534 | 3.510 |
Why?
|
| Pulmonary Alveoli | 19 | 2026 | 140 | 3.450 |
Why?
|
| Intellectual Disability | 42 | 2025 | 1087 | 3.420 |
Why?
|
| Developmental Disabilities | 35 | 2025 | 780 | 3.330 |
Why?
|
| Chromosome Deletion | 43 | 2025 | 654 | 3.180 |
Why?
|
| Genome, Human | 42 | 2025 | 1314 | 2.870 |
Why?
|
| Abnormalities, Multiple | 37 | 2021 | 964 | 2.870 |
Why?
|
| Phenotype | 60 | 2026 | 4472 | 2.780 |
Why?
|
| Lung Diseases | 6 | 2026 | 397 | 2.760 |
Why?
|
| RNA, Long Noncoding | 8 | 2021 | 217 | 2.710 |
Why?
|
| Gene Rearrangement | 20 | 2026 | 322 | 2.630 |
Why?
|
| Chromosome Aberrations | 34 | 2019 | 573 | 2.490 |
Why?
|
| Chromosomes, Human, Pair 17 | 26 | 2020 | 363 | 2.450 |
Why?
|
| Enhancer Elements, Genetic | 10 | 2023 | 269 | 2.440 |
Why?
|
| Chromosomes, Human, Pair 16 | 18 | 2019 | 148 | 2.300 |
Why?
|
| Exons | 19 | 2026 | 760 | 1.980 |
Why?
|
| Gene Deletion | 21 | 2019 | 767 | 1.980 |
Why?
|
| Polymorphism, Single Nucleotide | 20 | 2025 | 2826 | 1.910 |
Why?
|
| Genetic Predisposition to Disease | 21 | 2024 | 3406 | 1.900 |
Why?
|
| Genetic Diseases, Inborn | 12 | 2020 | 468 | 1.700 |
Why?
|
| In Situ Hybridization, Fluorescence | 58 | 2016 | 742 | 1.690 |
Why?
|
| Translocation, Genetic | 22 | 2020 | 344 | 1.670 |
Why?
|
| Pedigree | 35 | 2026 | 1673 | 1.630 |
Why?
|
| Language Development Disorders | 13 | 2021 | 176 | 1.580 |
Why?
|
| Infant, Newborn | 48 | 2026 | 8519 | 1.560 |
Why?
|
| Chromosome Breakage | 17 | 2011 | 154 | 1.520 |
Why?
|
| Genetic Association Studies | 12 | 2026 | 822 | 1.520 |
Why?
|
| Humans | 249 | 2026 | 130436 | 1.510 |
Why?
|
| Transcription Factors | 20 | 2025 | 2423 | 1.490 |
Why?
|
| Pulmonary Veins | 9 | 2020 | 166 | 1.420 |
Why?
|
| Microcephaly | 12 | 2021 | 348 | 1.410 |
Why?
|
| Haploinsufficiency | 11 | 2025 | 265 | 1.400 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 24 | 2025 | 995 | 1.360 |
Why?
|
| Female | 159 | 2026 | 70351 | 1.360 |
Why?
|
| Gene Dosage | 25 | 2020 | 436 | 1.360 |
Why?
|
| SOX9 Transcription Factor | 5 | 2017 | 86 | 1.350 |
Why?
|
| Nerve Tissue Proteins | 9 | 2019 | 1082 | 1.320 |
Why?
|
| Promoter Regions, Genetic | 5 | 2026 | 1210 | 1.290 |
Why?
|
| Epilepsy | 12 | 2024 | 863 | 1.270 |
Why?
|
| Frameshift Mutation | 5 | 2026 | 202 | 1.250 |
Why?
|
| Male | 153 | 2026 | 64471 | 1.230 |
Why?
|
| Chromosome Disorders | 16 | 2025 | 316 | 1.210 |
Why?
|
| Sequence Analysis, DNA | 21 | 2020 | 1693 | 1.170 |
Why?
|
| Child Development Disorders, Pervasive | 5 | 2013 | 82 | 1.140 |
Why?
|
| Exome | 4 | 2021 | 1063 | 1.100 |
Why?
|
| Mutation | 26 | 2024 | 6098 | 1.100 |
Why?
|
| Patella | 3 | 2026 | 28 | 1.080 |
Why?
|
| Infant | 61 | 2025 | 13228 | 1.020 |
Why?
|
| Chromosomes, Human, Pair 15 | 7 | 2016 | 143 | 1.010 |
Why?
|
| Chromosomes, Human | 9 | 2023 | 119 | 1.010 |
Why?
|
| Fibroblast Growth Factor 10 | 3 | 2022 | 21 | 1.000 |
Why?
|
| Genomic Imprinting | 7 | 2019 | 122 | 0.990 |
Why?
|
| Lower Extremity Deformities, Congenital | 1 | 2026 | 9 | 0.980 |
Why?
|
| Autistic Disorder | 12 | 2024 | 395 | 0.980 |
Why?
|
| Segmental Duplications, Genomic | 13 | 2023 | 81 | 0.950 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2026 | 39 | 0.940 |
Why?
|
| Child, Preschool | 72 | 2025 | 14943 | 0.940 |
Why?
|
| Base Sequence | 28 | 2018 | 2734 | 0.930 |
Why?
|
| Evolution, Molecular | 12 | 2022 | 645 | 0.920 |
Why?
|
| Genomic Instability | 7 | 2018 | 245 | 0.910 |
Why?
|
| Craniofacial Abnormalities | 9 | 2019 | 251 | 0.910 |
Why?
|
| Polymerase Chain Reaction | 12 | 2020 | 1456 | 0.910 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 15 | 2014 | 330 | 0.870 |
Why?
|
| Facies | 9 | 2021 | 157 | 0.870 |
Why?
|
| Molecular Sequence Data | 26 | 2015 | 3469 | 0.870 |
Why?
|
| Heterozygote | 6 | 2019 | 725 | 0.860 |
Why?
|
| Gene Expression Regulation | 11 | 2021 | 2333 | 0.860 |
Why?
|
| Mutation, Missense | 13 | 2024 | 922 | 0.860 |
Why?
|
| Chromosome Mapping | 24 | 2020 | 1046 | 0.860 |
Why?
|
| Membrane Proteins | 13 | 2023 | 1592 | 0.850 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2025 | 356 | 0.840 |
Why?
|
| High-Throughput Nucleotide Sequencing | 6 | 2021 | 891 | 0.820 |
Why?
|
| Hypertension, Pulmonary | 5 | 2026 | 453 | 0.810 |
Why?
|
| Chromosomes, Human, X | 7 | 2015 | 154 | 0.790 |
Why?
|
| DNA Methylation | 5 | 2023 | 1073 | 0.790 |
Why?
|
| Child | 81 | 2025 | 26094 | 0.760 |
Why?
|
| Fanconi Anemia | 1 | 2023 | 48 | 0.760 |
Why?
|
| Organogenesis | 2 | 2022 | 76 | 0.740 |
Why?
|
| Seizures | 7 | 2018 | 876 | 0.740 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 2021 | 152 | 0.720 |
Why?
|
| Trisomy | 7 | 2008 | 111 | 0.700 |
Why?
|
| Transcriptome | 2 | 2022 | 1115 | 0.700 |
Why?
|
| Adolescent | 57 | 2025 | 20725 | 0.700 |
Why?
|
| Uniparental Disomy | 2 | 2019 | 42 | 0.690 |
Why?
|
| Semaphorins | 1 | 2021 | 39 | 0.680 |
Why?
|
| Genetic Structures | 1 | 2021 | 3 | 0.680 |
Why?
|
| Neurodevelopmental Disorders | 5 | 2021 | 628 | 0.680 |
Why?
|
| Hedgehog Proteins | 2 | 2021 | 198 | 0.670 |
Why?
|
| DNA Mutational Analysis | 13 | 2020 | 779 | 0.670 |
Why?
|
| Genetic Variation | 7 | 2020 | 1541 | 0.660 |
Why?
|
| Alleles | 11 | 2020 | 1675 | 0.650 |
Why?
|
| Chromosomes, Human, Pair 7 | 5 | 2015 | 77 | 0.640 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2023 | 330 | 0.640 |
Why?
|
| Antigens, Nuclear | 2 | 2017 | 52 | 0.630 |
Why?
|
| Siblings | 6 | 2026 | 201 | 0.620 |
Why?
|
| Endogenous Retroviruses | 3 | 2014 | 18 | 0.610 |
Why?
|
| Proteins | 8 | 2019 | 1008 | 0.600 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2020 | 525 | 0.600 |
Why?
|
| Fatal Outcome | 6 | 2023 | 356 | 0.590 |
Why?
|
| Silver-Russell Syndrome | 1 | 2019 | 2 | 0.590 |
Why?
|
| DNA-Binding Proteins | 4 | 2023 | 1948 | 0.570 |
Why?
|
| Gametogenesis | 3 | 2017 | 26 | 0.570 |
Why?
|
| Genomics | 12 | 2025 | 1618 | 0.560 |
Why?
|
| Smith-Magenis Syndrome | 3 | 2018 | 107 | 0.560 |
Why?
|
| Syndrome | 20 | 2025 | 1158 | 0.560 |
Why?
|
| Genes, Lethal | 3 | 2016 | 72 | 0.550 |
Why?
|
| beta Catenin | 1 | 2019 | 198 | 0.540 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 3 | 2018 | 82 | 0.540 |
Why?
|
| Charcot-Marie-Tooth Disease | 8 | 2018 | 237 | 0.530 |
Why?
|
| Gene Editing | 2 | 2017 | 237 | 0.530 |
Why?
|
| Adult | 52 | 2025 | 31120 | 0.520 |
Why?
|
| High Mobility Group Proteins | 3 | 2007 | 33 | 0.520 |
Why?
|
| CRISPR-Cas Systems | 2 | 2017 | 316 | 0.520 |
Why?
|
| Chromosomes, Human, Pair 9 | 6 | 2025 | 109 | 0.510 |
Why?
|
| Homeodomain Proteins | 6 | 2017 | 562 | 0.510 |
Why?
|
| Mental Disorders | 7 | 2019 | 903 | 0.510 |
Why?
|
| Bone Diseases, Developmental | 3 | 2026 | 61 | 0.500 |
Why?
|
| Alu Elements | 7 | 2018 | 66 | 0.490 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2022 | 968 | 0.490 |
Why?
|
| Muscle Hypotonia | 4 | 2013 | 194 | 0.480 |
Why?
|
| Chromosomes, Human, Pair 14 | 3 | 2019 | 94 | 0.470 |
Why?
|
| Karyotyping | 17 | 2020 | 308 | 0.470 |
Why?
|
| Whole Genome Sequencing | 4 | 2026 | 359 | 0.470 |
Why?
|
| Chromatin | 2 | 2017 | 504 | 0.460 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2017 | 966 | 0.460 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2015 | 5 | 0.460 |
Why?
|
| Hominidae | 3 | 2023 | 27 | 0.450 |
Why?
|
| Signal Transduction | 4 | 2021 | 4670 | 0.450 |
Why?
|
| Nucleic Acid Hybridization | 6 | 2007 | 296 | 0.450 |
Why?
|
| Parents | 6 | 2024 | 1116 | 0.450 |
Why?
|
| Chromosome Breakpoints | 9 | 2017 | 82 | 0.450 |
Why?
|
| Germ-Line Mutation | 2 | 2014 | 372 | 0.450 |
Why?
|
| Homologous Recombination | 6 | 2015 | 97 | 0.440 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2015 | 60 | 0.440 |
Why?
|
| Pierre Robin Syndrome | 1 | 2015 | 42 | 0.430 |
Why?
|
| Recombination, Genetic | 10 | 2012 | 422 | 0.430 |
Why?
|
| Chromosome Inversion | 4 | 2020 | 70 | 0.430 |
Why?
|
| Genome-Wide Association Study | 3 | 2019 | 1824 | 0.430 |
Why?
|
| Microarray Analysis | 11 | 2020 | 223 | 0.420 |
Why?
|
| Germ Cells | 2 | 2014 | 201 | 0.410 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 5 | 2017 | 52 | 0.410 |
Why?
|
| Point Mutation | 3 | 2018 | 332 | 0.410 |
Why?
|
| Chromosomes, Human, Pair 6 | 5 | 2014 | 137 | 0.410 |
Why?
|
| Chromosome Banding | 16 | 2014 | 135 | 0.410 |
Why?
|
| Receptors, Cell Surface | 4 | 2014 | 421 | 0.400 |
Why?
|
| Autism Spectrum Disorder | 5 | 2024 | 450 | 0.400 |
Why?
|
| DNA, Viral | 2 | 2014 | 452 | 0.400 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2023 | 217 | 0.400 |
Why?
|
| Introns | 2 | 2013 | 279 | 0.390 |
Why?
|
| Williams Syndrome | 5 | 2019 | 42 | 0.390 |
Why?
|
| Chromosomes, Human, Pair 2 | 3 | 2013 | 121 | 0.390 |
Why?
|
| Genomic Structural Variation | 2 | 2015 | 96 | 0.390 |
Why?
|
| Inheritance Patterns | 4 | 2020 | 127 | 0.380 |
Why?
|
| Disorders of Sex Development | 4 | 2007 | 69 | 0.380 |
Why?
|
| Receptors, Nicotinic | 2 | 2010 | 113 | 0.380 |
Why?
|
| DiGeorge Syndrome | 5 | 2018 | 83 | 0.380 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 137 | 0.370 |
Why?
|
| Fractures, Bone | 1 | 2015 | 214 | 0.370 |
Why?
|
| Models, Genetic | 7 | 2018 | 748 | 0.370 |
Why?
|
| DNA | 11 | 2012 | 1400 | 0.370 |
Why?
|
| Nuclear Proteins | 6 | 2012 | 1218 | 0.360 |
Why?
|
| Mouth Mucosa | 2 | 2022 | 45 | 0.360 |
Why?
|
| Vesicular Acetylcholine Transport Proteins | 1 | 2011 | 5 | 0.360 |
Why?
|
| Chromosome Duplication | 7 | 2018 | 146 | 0.350 |
Why?
|
| Genotype | 10 | 2020 | 2589 | 0.350 |
Why?
|
| Young Adult | 23 | 2025 | 9993 | 0.350 |
Why?
|
| Levodopa | 1 | 2012 | 91 | 0.350 |
Why?
|
| Nerve Growth Factors | 1 | 2011 | 67 | 0.350 |
Why?
|
| Dopaminergic Neurons | 1 | 2012 | 59 | 0.350 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2012 | 102 | 0.340 |
Why?
|
| CpG Islands | 3 | 2019 | 334 | 0.340 |
Why?
|
| Self-Injurious Behavior | 1 | 2012 | 66 | 0.340 |
Why?
|
| Mutagenesis, Insertional | 4 | 2020 | 151 | 0.340 |
Why?
|
| Pregnancy | 13 | 2022 | 7394 | 0.330 |
Why?
|
| Telomere | 8 | 2023 | 218 | 0.330 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2011 | 104 | 0.330 |
Why?
|
| MADS Domain Proteins | 1 | 2010 | 3 | 0.330 |
Why?
|
| Genetic Testing | 3 | 2024 | 1107 | 0.320 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2010 | 14 | 0.320 |
Why?
|
| Repressor Proteins | 3 | 2021 | 763 | 0.320 |
Why?
|
| Cognition Disorders | 5 | 2013 | 552 | 0.320 |
Why?
|
| Carrier Proteins | 4 | 2025 | 1000 | 0.320 |
Why?
|
| Mutagenesis | 2 | 2017 | 325 | 0.320 |
Why?
|
| Animals | 32 | 2025 | 33857 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 10 | 4 | 2012 | 67 | 0.320 |
Why?
|
| Sequence Homology, Nucleic Acid | 5 | 2009 | 252 | 0.310 |
Why?
|
| Sodium Channels | 1 | 2010 | 97 | 0.310 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 294 | 0.310 |
Why?
|
| Cells, Cultured | 3 | 2021 | 2894 | 0.300 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2009 | 14 | 0.300 |
Why?
|
| Cytogenetic Analysis | 8 | 2012 | 78 | 0.300 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2020 | 144 | 0.300 |
Why?
|
| MEF2 Transcription Factors | 2 | 2024 | 34 | 0.300 |
Why?
|
| Ischium | 2 | 2026 | 4 | 0.290 |
Why?
|
| 14-3-3 Proteins | 1 | 2009 | 56 | 0.290 |
Why?
|
| Genome | 4 | 2023 | 453 | 0.290 |
Why?
|
| Hip | 2 | 2026 | 21 | 0.290 |
Why?
|
| Growth Disorders | 3 | 2005 | 183 | 0.290 |
Why?
|
| De Lange Syndrome | 3 | 2019 | 44 | 0.280 |
Why?
|
| Gene Order | 7 | 2013 | 81 | 0.280 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2021 | 122 | 0.280 |
Why?
|
| Gene Silencing | 1 | 2009 | 231 | 0.280 |
Why?
|
| DNA Replication | 5 | 2019 | 356 | 0.280 |
Why?
|
| Cell Line | 9 | 2017 | 2557 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 20 | 2 | 2013 | 31 | 0.280 |
Why?
|
| Primates | 3 | 2007 | 81 | 0.270 |
Why?
|
| Disease | 1 | 2009 | 121 | 0.270 |
Why?
|
| Nervous System Malformations | 1 | 2009 | 136 | 0.270 |
Why?
|
| Chromosomes, Human, Pair 1 | 5 | 2022 | 145 | 0.270 |
Why?
|
| Transcription, Genetic | 5 | 2021 | 1367 | 0.260 |
Why?
|
| Congenital Abnormalities | 3 | 2008 | 323 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 21 | 2 | 2008 | 34 | 0.260 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2007 | 77 | 0.260 |
Why?
|
| Cohort Studies | 12 | 2025 | 5034 | 0.260 |
Why?
|
| Sex Chromosome Aberrations | 2 | 2011 | 59 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 22 | 5 | 2012 | 97 | 0.250 |
Why?
|
| Mothers | 3 | 2025 | 376 | 0.250 |
Why?
|
| Gene Expression | 5 | 2023 | 1486 | 0.250 |
Why?
|
| Long Interspersed Nucleotide Elements | 5 | 2018 | 38 | 0.240 |
Why?
|
| Brain | 5 | 2019 | 3174 | 0.240 |
Why?
|
| RNA Interference | 2 | 2021 | 493 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 5 | 5 | 2016 | 108 | 0.240 |
Why?
|
| Radiography | 3 | 2019 | 740 | 0.240 |
Why?
|
| Keratoconus | 2 | 2016 | 51 | 0.230 |
Why?
|
| Campomelic Dysplasia | 2 | 2017 | 4 | 0.230 |
Why?
|
| Algorithms | 5 | 2023 | 1663 | 0.230 |
Why?
|
| Speech Disorders | 1 | 2005 | 46 | 0.230 |
Why?
|
| Protein Binding | 2 | 2021 | 1656 | 0.220 |
Why?
|
| Binding Sites | 3 | 2017 | 1136 | 0.220 |
Why?
|
| Zebrafish | 5 | 2021 | 417 | 0.220 |
Why?
|
| Vomiting | 1 | 2025 | 103 | 0.210 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2017 | 246 | 0.210 |
Why?
|
| Genetic Markers | 4 | 2015 | 590 | 0.210 |
Why?
|
| Genetic Counseling | 2 | 2024 | 237 | 0.210 |
Why?
|
| Acinar Cells | 1 | 2023 | 10 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 4 | 3 | 2011 | 53 | 0.210 |
Why?
|
| X Chromosome | 2 | 2002 | 326 | 0.200 |
Why?
|
| Isochromosomes | 3 | 2012 | 17 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2017 | 585 | 0.200 |
Why?
|
| Hydronephrosis | 1 | 2023 | 34 | 0.190 |
Why?
|
| Aneuploidy | 4 | 2014 | 136 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 3 | 3 | 2013 | 89 | 0.190 |
Why?
|
| Penetrance | 3 | 2018 | 108 | 0.190 |
Why?
|
| Poland | 4 | 2020 | 56 | 0.190 |
Why?
|
| Mice | 15 | 2025 | 18229 | 0.180 |
Why?
|
| Alagille Syndrome | 2 | 2008 | 54 | 0.180 |
Why?
|
| Genetic Linkage | 2 | 2016 | 461 | 0.180 |
Why?
|
| Calcium-Binding Proteins | 5 | 2018 | 322 | 0.180 |
Why?
|
| Amino Acid Sequence | 6 | 2013 | 2397 | 0.180 |
Why?
|
| Pregnancy Trimester, First | 1 | 2022 | 115 | 0.180 |
Why?
|
| Ring Chromosomes | 1 | 2001 | 12 | 0.170 |
Why?
|
| Prader-Willi Syndrome | 2 | 2018 | 62 | 0.170 |
Why?
|
| Centromere | 5 | 2022 | 67 | 0.170 |
Why?
|
| Respiratory System Abnormalities | 1 | 2022 | 42 | 0.170 |
Why?
|
| Solute Carrier Proteins | 1 | 2021 | 2 | 0.170 |
Why?
|
| DNA Repair | 3 | 2015 | 570 | 0.170 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 1807 | 0.170 |
Why?
|
| Databases, Genetic | 4 | 2015 | 500 | 0.170 |
Why?
|
| Larva | 2 | 2021 | 244 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 11 | 3 | 2011 | 87 | 0.170 |
Why?
|
| Computational Biology | 5 | 2023 | 862 | 0.170 |
Why?
|
| RNA, Untranslated | 1 | 2001 | 109 | 0.170 |
Why?
|
| Age of Onset | 5 | 2018 | 595 | 0.160 |
Why?
|
| Counseling | 1 | 2022 | 235 | 0.160 |
Why?
|
| Organ Specificity | 1 | 2021 | 396 | 0.160 |
Why?
|
| Histone Deacetylases | 1 | 2021 | 131 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 382 | 0.160 |
Why?
|
| Multigene Family | 3 | 2013 | 289 | 0.160 |
Why?
|
| Myopia | 1 | 2021 | 121 | 0.160 |
Why?
|
| Protein Isoforms | 3 | 2016 | 423 | 0.160 |
Why?
|
| Branchio-Oto-Renal Syndrome | 2 | 2010 | 11 | 0.160 |
Why?
|
| Fetal Development | 1 | 2021 | 121 | 0.150 |
Why?
|
| Middle Aged | 15 | 2024 | 28395 | 0.150 |
Why?
|
| Software | 2 | 2023 | 731 | 0.150 |
Why?
|
| Base Pairing | 2 | 2012 | 40 | 0.150 |
Why?
|
| Tandem Repeat Sequences | 1 | 2019 | 37 | 0.150 |
Why?
|
| Electroencephalography | 1 | 2024 | 849 | 0.150 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 278 | 0.150 |
Why?
|
| Sequence Alignment | 5 | 2013 | 583 | 0.150 |
Why?
|
| X Chromosome Inactivation | 3 | 2014 | 59 | 0.150 |
Why?
|
| Genetic Loci | 1 | 2021 | 353 | 0.150 |
Why?
|
| INDEL Mutation | 1 | 2019 | 93 | 0.150 |
Why?
|
| Muscle Spasticity | 1 | 2019 | 51 | 0.150 |
Why?
|
| Karyotype | 2 | 2016 | 30 | 0.140 |
Why?
|
| Membrane Glycoproteins | 1 | 2021 | 409 | 0.140 |
Why?
|
| Genetic Carrier Screening | 1 | 2018 | 66 | 0.140 |
Why?
|
| Embryonic Development | 2 | 2017 | 201 | 0.140 |
Why?
|
| Intestinal Volvulus | 1 | 2019 | 41 | 0.140 |
Why?
|
| Neural Cell Adhesion Molecules | 3 | 2018 | 18 | 0.140 |
Why?
|
| Digestive System Abnormalities | 1 | 2019 | 38 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 18 | 3 | 2019 | 59 | 0.140 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2019 | 67 | 0.140 |
Why?
|
| Methyltransferases | 1 | 2018 | 78 | 0.130 |
Why?
|
| Hernia, Diaphragmatic | 2 | 2010 | 91 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2024 | 889 | 0.130 |
Why?
|
| Mice, Knockout | 2 | 2017 | 3830 | 0.130 |
Why?
|
| Genes, Recessive | 4 | 2013 | 195 | 0.130 |
Why?
|
| Neurons | 4 | 2024 | 2027 | 0.130 |
Why?
|
| Microsatellite Repeats | 4 | 2007 | 204 | 0.130 |
Why?
|
| Megalencephaly | 2 | 2014 | 59 | 0.130 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2016 | 19 | 0.130 |
Why?
|
| Hexokinase | 1 | 2016 | 22 | 0.120 |
Why?
|
| YY1 Transcription Factor | 1 | 2016 | 18 | 0.120 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 132 | 0.120 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2019 | 177 | 0.120 |
Why?
|
| Neoplasms | 3 | 2024 | 2969 | 0.120 |
Why?
|
| Caveolin 3 | 1 | 2016 | 6 | 0.120 |
Why?
|
| Myalgia | 1 | 2016 | 9 | 0.120 |
Why?
|
| GATA3 Transcription Factor | 1 | 2016 | 44 | 0.120 |
Why?
|
| Creatine Kinase | 1 | 2016 | 64 | 0.120 |
Why?
|
| Case-Control Studies | 2 | 2021 | 3355 | 0.120 |
Why?
|
| Autopsy | 1 | 2016 | 113 | 0.120 |
Why?
|
| Skin | 1 | 2019 | 536 | 0.120 |
Why?
|
| Basal Cell Nevus Syndrome | 2 | 2007 | 15 | 0.120 |
Why?
|
| Homozygote | 2 | 2019 | 535 | 0.120 |
Why?
|
| Interleukin-17 | 1 | 2016 | 125 | 0.120 |
Why?
|
| Chorionic Villi Sampling | 1 | 2015 | 44 | 0.120 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 238 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 1595 | 0.120 |
Why?
|
| Risk | 2 | 2015 | 722 | 0.120 |
Why?
|
| Radiography, Thoracic | 1 | 2016 | 145 | 0.120 |
Why?
|
| Steroidogenic Factor 1 | 2 | 2013 | 33 | 0.120 |
Why?
|
| Recurrence | 3 | 2014 | 1472 | 0.110 |
Why?
|
| Alternative Splicing | 2 | 2016 | 310 | 0.110 |
Why?
|
| Osteochondritis | 1 | 2015 | 2 | 0.110 |
Why?
|
| Metatarsus | 1 | 2015 | 2 | 0.110 |
Why?
|
| Cri-du-Chat Syndrome | 1 | 2015 | 4 | 0.110 |
Why?
|
| Models, Theoretical | 2 | 2014 | 361 | 0.110 |
Why?
|
| Brachydactyly | 1 | 2015 | 10 | 0.110 |
Why?
|
| Fibroblasts | 1 | 2019 | 852 | 0.110 |
Why?
|
| Minisatellite Repeats | 1 | 2014 | 43 | 0.110 |
Why?
|
| Loss of Heterozygosity | 1 | 2015 | 123 | 0.110 |
Why?
|
| Chromosomes, Artificial, Bacterial | 5 | 2007 | 87 | 0.110 |
Why?
|
| HEK293 Cells | 2 | 2018 | 805 | 0.110 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2014 | 30 | 0.110 |
Why?
|
| Family | 4 | 2011 | 585 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 198 | 0.100 |
Why?
|
| Microchip Analytical Procedures | 1 | 2013 | 4 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 538 | 0.100 |
Why?
|
| Cation Transport Proteins | 1 | 2014 | 101 | 0.100 |
Why?
|
| SOXC Transcription Factors | 1 | 2013 | 13 | 0.100 |
Why?
|
| Sertoli Cells | 1 | 2013 | 73 | 0.100 |
Why?
|
| Adenosine Triphosphatases | 1 | 2014 | 190 | 0.100 |
Why?
|
| Tetraspanins | 1 | 2013 | 30 | 0.100 |
Why?
|
| Aging, Premature | 1 | 2013 | 31 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2021 | 3749 | 0.100 |
Why?
|
| Estrogen Receptor alpha | 1 | 2016 | 426 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 1875 | 0.100 |
Why?
|
| Heart Defects, Congenital | 3 | 2012 | 1872 | 0.100 |
Why?
|
| Family Health | 3 | 2010 | 241 | 0.100 |
Why?
|
| Molecular Chaperones | 2 | 2012 | 173 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 192 | 0.100 |
Why?
|
| Genotyping Techniques | 1 | 2013 | 110 | 0.100 |
Why?
|
| Lung Transplantation | 1 | 2017 | 352 | 0.100 |
Why?
|
| Cell Division | 1 | 2014 | 718 | 0.100 |
Why?
|
| Membrane Transport Proteins | 1 | 2014 | 178 | 0.100 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2013 | 51 | 0.100 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2012 | 12 | 0.100 |
Why?
|
| Myelin Proteins | 2 | 2004 | 79 | 0.090 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 62 | 0.090 |
Why?
|
| Open Reading Frames | 1 | 2013 | 198 | 0.090 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2013 | 92 | 0.090 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2012 | 16 | 0.090 |
Why?
|
| Munc18 Proteins | 1 | 2012 | 21 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2014 | 2551 | 0.090 |
Why?
|
| Sex Characteristics | 1 | 2014 | 323 | 0.090 |
Why?
|
| Cell Cycle Proteins | 3 | 2015 | 710 | 0.090 |
Why?
|
| Bayes Theorem | 1 | 2013 | 307 | 0.090 |
Why?
|
| Hyperkinesis | 1 | 2012 | 27 | 0.090 |
Why?
|
| Dopamine Agents | 1 | 2012 | 27 | 0.090 |
Why?
|
| Pneumonia, Aspiration | 1 | 2012 | 18 | 0.090 |
Why?
|
| Patched Receptors | 2 | 2008 | 27 | 0.090 |
Why?
|
| Sex Chromosome Disorders | 1 | 2011 | 9 | 0.090 |
Why?
|
| Y Chromosome | 2 | 2002 | 47 | 0.090 |
Why?
|
| Ear, Inner | 1 | 2012 | 41 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2012 | 109 | 0.090 |
Why?
|
| Patched-1 Receptor | 2 | 2008 | 38 | 0.090 |
Why?
|
| Preimplantation Diagnosis | 1 | 2012 | 28 | 0.090 |
Why?
|
| Deafness | 1 | 2012 | 79 | 0.090 |
Why?
|
| Mixed Function Oxygenases | 1 | 2011 | 36 | 0.090 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2011 | 49 | 0.090 |
Why?
|
| Holoprosencephaly | 1 | 2011 | 23 | 0.090 |
Why?
|
| Schizophrenia | 2 | 2012 | 323 | 0.090 |
Why?
|
| Cognitive Dysfunction | 1 | 2016 | 339 | 0.080 |
Why?
|
| Face | 3 | 2009 | 189 | 0.080 |
Why?
|
| Haplotypes | 1 | 2012 | 517 | 0.080 |
Why?
|
| NAV1.3 Voltage-Gated Sodium Channel | 1 | 2010 | 3 | 0.080 |
Why?
|
| Anemia, Diamond-Blackfan | 1 | 2010 | 12 | 0.080 |
Why?
|
| Reproducibility of Results | 3 | 2012 | 2896 | 0.080 |
Why?
|
| Rhombencephalon | 1 | 2011 | 63 | 0.080 |
Why?
|
| Rubinstein-Taybi Syndrome | 1 | 2010 | 16 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2010 | 76 | 0.080 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2008 | 166 | 0.080 |
Why?
|
| Animals, Newborn | 1 | 2014 | 1015 | 0.080 |
Why?
|
| NAV1.2 Voltage-Gated Sodium Channel | 1 | 2010 | 9 | 0.080 |
Why?
|
| Biopsy | 1 | 2014 | 1244 | 0.080 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 269 | 0.080 |
Why?
|
| CREB-Binding Protein | 1 | 2010 | 55 | 0.080 |
Why?
|
| Calmodulin | 1 | 2011 | 210 | 0.080 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2010 | 50 | 0.080 |
Why?
|
| Spasms, Infantile | 1 | 2012 | 165 | 0.080 |
Why?
|
| Antigens, CD | 1 | 2012 | 411 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2017 | 2464 | 0.080 |
Why?
|
| Diaphragm | 1 | 2011 | 100 | 0.080 |
Why?
|
| Heterochromatin | 2 | 2007 | 53 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 3 | 2018 | 260 | 0.080 |
Why?
|
| Gene Frequency | 3 | 2016 | 731 | 0.070 |
Why?
|
| Capillaries | 1 | 2009 | 64 | 0.070 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2009 | 91 | 0.070 |
Why?
|
| Limb Deformities, Congenital | 1 | 2010 | 114 | 0.070 |
Why?
|
| Jacobsen Distal 11q Deletion Syndrome | 1 | 2008 | 1 | 0.070 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2010 | 211 | 0.070 |
Why?
|
| Cerebellar Neoplasms | 1 | 2012 | 316 | 0.070 |
Why?
|
| Body Height | 1 | 2009 | 194 | 0.070 |
Why?
|
| Goldenhar Syndrome | 1 | 2008 | 15 | 0.070 |
Why?
|
| Otx Transcription Factors | 1 | 2008 | 25 | 0.070 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2009 | 83 | 0.070 |
Why?
|
| Single-Cell Analysis | 1 | 2012 | 352 | 0.070 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2008 | 86 | 0.070 |
Why?
|
| Medulloblastoma | 1 | 2012 | 376 | 0.070 |
Why?
|
| Cleidocranial Dysplasia | 1 | 2008 | 6 | 0.070 |
Why?
|
| Fathers | 2 | 2022 | 74 | 0.070 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2008 | 74 | 0.070 |
Why?
|
| Doxorubicin | 1 | 2009 | 288 | 0.070 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2009 | 251 | 0.070 |
Why?
|
| Syndactyly | 1 | 2007 | 24 | 0.070 |
Why?
|
| DAX-1 Orphan Nuclear Receptor | 1 | 2007 | 7 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 2008 | 48 | 0.070 |
Why?
|
| Gonads | 1 | 2007 | 32 | 0.060 |
Why?
|
| Trans-Activators | 2 | 2008 | 701 | 0.060 |
Why?
|
| AT Rich Sequence | 1 | 2007 | 2 | 0.060 |
Why?
|
| Hybrid Cells | 1 | 2007 | 77 | 0.060 |
Why?
|
| Chromosomes, Artificial, P1 Bacteriophage | 2 | 2004 | 6 | 0.060 |
Why?
|
| Chromosomes, Human, Y | 1 | 2007 | 52 | 0.060 |
Why?
|
| Thrombocytopenia | 1 | 2008 | 219 | 0.060 |
Why?
|
| Serrate-Jagged Proteins | 2 | 2008 | 35 | 0.060 |
Why?
|
| Hearing Loss | 1 | 2008 | 204 | 0.060 |
Why?
|
| Crossing Over, Genetic | 2 | 2005 | 52 | 0.060 |
Why?
|
| Pelizaeus-Merzbacher Disease | 1 | 2006 | 22 | 0.060 |
Why?
|
| Jagged-1 Protein | 2 | 2008 | 51 | 0.060 |
Why?
|
| Synteny | 2 | 2006 | 66 | 0.060 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2006 | 28 | 0.060 |
Why?
|
| snRNP Core Proteins | 1 | 2006 | 8 | 0.060 |
Why?
|
| Physical Chromosome Mapping | 2 | 2003 | 55 | 0.060 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2009 | 284 | 0.060 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2006 | 16 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 395 | 0.060 |
Why?
|
| Gorilla gorilla | 2 | 2007 | 12 | 0.060 |
Why?
|
| Prognosis | 4 | 2021 | 4861 | 0.060 |
Why?
|
| Endopeptidases | 1 | 2006 | 106 | 0.060 |
Why?
|
| Oncogene Proteins | 1 | 2006 | 136 | 0.060 |
Why?
|
| Interphase | 1 | 2005 | 37 | 0.060 |
Why?
|
| Autoantigens | 1 | 2006 | 100 | 0.060 |
Why?
|
| WAGR Syndrome | 1 | 2005 | 7 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 1268 | 0.060 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2005 | 58 | 0.060 |
Why?
|
| Primary Myelofibrosis | 1 | 2005 | 51 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2008 | 289 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2007 | 319 | 0.050 |
Why?
|
| Methicillin Resistance | 1 | 2005 | 116 | 0.050 |
Why?
|
| Nail-Patella Syndrome | 1 | 2004 | 2 | 0.050 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2005 | 70 | 0.050 |
Why?
|
| Klebsiella Infections | 1 | 2004 | 58 | 0.050 |
Why?
|
| Base Composition | 3 | 2013 | 66 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2005 | 321 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2014 | 6424 | 0.050 |
Why?
|
| HIV-1 | 1 | 2007 | 492 | 0.050 |
Why?
|
| Community-Acquired Infections | 1 | 2005 | 252 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 776 | 0.050 |
Why?
|
| Neurogenesis | 1 | 2024 | 213 | 0.050 |
Why?
|
| Gene Conversion | 1 | 2002 | 14 | 0.050 |
Why?
|
| Chaperonins | 1 | 2002 | 15 | 0.050 |
Why?
|
| Receptors, Androgen | 1 | 2005 | 408 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 88 | 0.050 |
Why?
|
| Proton-Translocating ATPases | 1 | 2002 | 25 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2024 | 247 | 0.040 |
Why?
|
| Prenatal Diagnosis | 1 | 2006 | 611 | 0.040 |
Why?
|
| Pseudogenes | 3 | 2007 | 50 | 0.040 |
Why?
|
| Behavior | 1 | 2002 | 70 | 0.040 |
Why?
|
| Toes | 1 | 2001 | 27 | 0.040 |
Why?
|
| Cosmids | 1 | 2001 | 38 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 2001 | 203 | 0.040 |
Why?
|
| Genetic Techniques | 1 | 2002 | 96 | 0.040 |
Why?
|
| Osteochondrodysplasias | 1 | 2002 | 68 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 6788 | 0.040 |
Why?
|
| Twist-Related Protein 1 | 1 | 2001 | 36 | 0.040 |
Why?
|
| Organoids | 1 | 2024 | 301 | 0.040 |
Why?
|
| Fingers | 1 | 2001 | 63 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2005 | 477 | 0.040 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 3 | 2007 | 91 | 0.040 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 2000 | 38 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2023 | 380 | 0.040 |
Why?
|
| Acetylation | 1 | 2021 | 191 | 0.040 |
Why?
|
| DNA End-Joining Repair | 1 | 2020 | 34 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2002 | 236 | 0.040 |
Why?
|
| Aged | 6 | 2019 | 20888 | 0.040 |
Why?
|
| RNA | 1 | 2023 | 515 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2002 | 260 | 0.040 |
Why?
|
| Obesity | 1 | 2012 | 2383 | 0.040 |
Why?
|
| Staphylococcal Infections | 1 | 2005 | 562 | 0.040 |
Why?
|
| Europe | 1 | 2021 | 364 | 0.040 |
Why?
|
| Survival Rate | 2 | 2017 | 2112 | 0.040 |
Why?
|
| Molecular Sequence Annotation | 1 | 2020 | 147 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2023 | 521 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2021 | 132 | 0.040 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2002 | 213 | 0.040 |
Why?
|
| Cell Line, Transformed | 2 | 2014 | 159 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 2099 | 0.040 |
Why?
|
| Fetus | 1 | 2023 | 567 | 0.040 |
Why?
|
| DNA Damage | 1 | 2003 | 510 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 74 | 0.040 |
Why?
|
| Paternal Inheritance | 1 | 2019 | 10 | 0.040 |
Why?
|
| Maternal Inheritance | 1 | 2019 | 12 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 37 | 0.040 |
Why?
|
| Genetic Background | 1 | 2018 | 7 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2013 | 54 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2020 | 404 | 0.040 |
Why?
|
| Rare Diseases | 1 | 2020 | 205 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2013 | 615 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2008 | 2088 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 2018 | 140 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2023 | 855 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2021 | 1061 | 0.030 |
Why?
|
| Models, Animal | 1 | 2019 | 451 | 0.030 |
Why?
|
| Protein Stability | 1 | 2018 | 165 | 0.030 |
Why?
|
| Neuroglia | 1 | 2019 | 224 | 0.030 |
Why?
|
| Histones | 1 | 2021 | 545 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2019 | 400 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2019 | 490 | 0.030 |
Why?
|
| Transcription Factor 4 | 1 | 2016 | 12 | 0.030 |
Why?
|
| Klinefelter Syndrome | 1 | 2016 | 20 | 0.030 |
Why?
|
| Hyperventilation | 1 | 2016 | 12 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2009 | 168 | 0.030 |
Why?
|
| Thigh | 1 | 2016 | 50 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2024 | 17510 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 2016 | 124 | 0.030 |
Why?
|
| Netherlands | 1 | 2015 | 50 | 0.030 |
Why?
|
| Diploidy | 1 | 2015 | 40 | 0.030 |
Why?
|
| Problem Behavior | 1 | 2015 | 39 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2015 | 141 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2012 | 2334 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 649 | 0.030 |
Why?
|
| Sjogren's Syndrome | 1 | 2016 | 108 | 0.030 |
Why?
|
| Spastin | 1 | 2014 | 8 | 0.030 |
Why?
|
| Gestational Age | 1 | 2019 | 1208 | 0.030 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2015 | 83 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 327 | 0.030 |
Why?
|
| Spine | 1 | 2015 | 150 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2019 | 837 | 0.030 |
Why?
|
| Colitis, Ulcerative | 1 | 2016 | 208 | 0.030 |
Why?
|
| Risk Factors | 3 | 2014 | 10948 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 388 | 0.030 |
Why?
|
| Respiratory Insufficiency | 1 | 2016 | 242 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2019 | 776 | 0.030 |
Why?
|
| Nucleotide Motifs | 1 | 2013 | 51 | 0.020 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 2 | 2010 | 401 | 0.020 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2013 | 44 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 1206 | 0.020 |
Why?
|
| Cognition | 1 | 2018 | 819 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 98 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2013 | 244 | 0.020 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2012 | 35 | 0.020 |
Why?
|
| Endoglin | 1 | 2012 | 30 | 0.020 |
Why?
|
| Contig Mapping | 2 | 2002 | 46 | 0.020 |
Why?
|
| Protein Interaction Maps | 1 | 2012 | 93 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 2012 | 84 | 0.020 |
Why?
|
| Child Behavior Disorders | 1 | 2012 | 72 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2014 | 692 | 0.020 |
Why?
|
| Eye Abnormalities | 1 | 2012 | 104 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 5153 | 0.020 |
Why?
|
| Spectrin | 1 | 2012 | 70 | 0.020 |
Why?
|
| Body Patterning | 1 | 2012 | 123 | 0.020 |
Why?
|
| Hemophilia A | 1 | 2011 | 28 | 0.020 |
Why?
|
| Fragile X Syndrome | 1 | 2012 | 148 | 0.020 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 3 | 1 | 2011 | 6 | 0.020 |
Why?
|
| Genes, X-Linked | 1 | 2011 | 60 | 0.020 |
Why?
|
| Prevalence | 1 | 2018 | 2683 | 0.020 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2011 | 32 | 0.020 |
Why?
|
| Receptors, Odorant | 1 | 2011 | 35 | 0.020 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2011 | 16 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2010 | 22 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2002 | 623 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2012 | 348 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 173 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2010 | 69 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2009 | 27 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 1002 | 0.020 |
Why?
|
| Inverted Repeat Sequences | 1 | 2009 | 12 | 0.020 |
Why?
|
| Codon, Nonsense | 1 | 2010 | 138 | 0.020 |
Why?
|
| Templates, Genetic | 1 | 2009 | 52 | 0.020 |
Why?
|
| DNA Breaks | 1 | 2009 | 25 | 0.020 |
Why?
|
| Down Syndrome | 1 | 2012 | 232 | 0.020 |
Why?
|
| NADPH Oxidases | 1 | 2008 | 109 | 0.020 |
Why?
|
| Genetic Drift | 1 | 2007 | 20 | 0.020 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2007 | 28 | 0.020 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2007 | 35 | 0.020 |
Why?
|
| Allelic Imbalance | 1 | 2007 | 11 | 0.020 |
Why?
|
| Genome, Mitochondrial | 1 | 2007 | 26 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 2007 | 45 | 0.020 |
Why?
|
| Sex Differentiation | 1 | 2007 | 18 | 0.020 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2007 | 32 | 0.020 |
Why?
|
| HIV Core Protein p24 | 1 | 2007 | 10 | 0.020 |
Why?
|
| Gene Products, gag | 1 | 2007 | 21 | 0.020 |
Why?
|
| Chromosome Painting | 1 | 2007 | 14 | 0.020 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2007 | 8 | 0.020 |
Why?
|
| Codon | 1 | 2007 | 92 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2007 | 48 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2007 | 223 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2007 | 91 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2007 | 151 | 0.020 |
Why?
|
| Rett Syndrome | 1 | 2009 | 229 | 0.020 |
Why?
|
| Terminal Repeat Sequences | 1 | 2006 | 20 | 0.020 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2006 | 17 | 0.020 |
Why?
|
| Genetics, Population | 1 | 2007 | 177 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2007 | 139 | 0.010 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2006 | 65 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2007 | 341 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 4667 | 0.010 |
Why?
|
| Fertilization in Vitro | 1 | 2007 | 151 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2007 | 231 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2007 | 809 | 0.010 |
Why?
|
| Language Disorders | 1 | 2005 | 21 | 0.010 |
Why?
|
| Reference Values | 1 | 2007 | 675 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2007 | 691 | 0.010 |
Why?
|
| PAX6 Transcription Factor | 1 | 2005 | 36 | 0.010 |
Why?
|
| WT1 Proteins | 1 | 2005 | 23 | 0.010 |
Why?
|
| Paired Box Transcription Factors | 1 | 2005 | 72 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2005 | 76 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2007 | 499 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2007 | 306 | 0.010 |
Why?
|
| Clone Cells | 1 | 2005 | 152 | 0.010 |
Why?
|
| Probability | 1 | 2005 | 305 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2007 | 572 | 0.010 |
Why?
|
| DNA Probes | 1 | 2004 | 118 | 0.010 |
Why?
|
| Blast Crisis | 1 | 2003 | 17 | 0.010 |
Why?
|
| Sleep Disorders, Intrinsic | 1 | 2003 | 3 | 0.010 |
Why?
|
| Eye Proteins | 1 | 2005 | 225 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2005 | 317 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2005 | 480 | 0.010 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2003 | 103 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2008 | 975 | 0.010 |
Why?
|
| Sleep Wake Disorders | 1 | 2005 | 202 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2006 | 599 | 0.010 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2002 | 27 | 0.010 |
Why?
|
| DNA Fingerprinting | 1 | 2002 | 106 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2005 | 850 | 0.010 |
Why?
|
| Consanguinity | 1 | 2002 | 116 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 2002 | 136 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2002 | 277 | 0.010 |
Why?
|
| Species Specificity | 1 | 2002 | 474 | 0.010 |
Why?
|
| Decision Making | 1 | 2006 | 711 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 780 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2000 | 234 | 0.010 |
Why?
|
| Bacteremia | 1 | 2005 | 429 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2000 | 364 | 0.010 |
Why?
|
| Genes | 1 | 2000 | 308 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2000 | 425 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 2005 | 797 | 0.010 |
Why?
|
| Renal Insufficiency | 1 | 2002 | 257 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 3717 | 0.010 |
Why?
|
| Echocardiography | 1 | 2004 | 1127 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 6200 | 0.010 |
Why?
|
| Incidence | 1 | 2005 | 3313 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 3029 | 0.010 |
Why?
|
| Texas | 1 | 2005 | 3642 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2005 | 3675 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 1712 | 0.010 |
Why?
|